As of 2026-03-20, the Relative Valuation of Kaleido Biosciences Inc (KLDO) is (32.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of Kaleido Biosciences Inc based on Relative Valuation is -32358585.5%.
The range of the Relative Valuation is (22.50) - (35.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 18.1x | 16.2x |
| Forward P/E multiples | 9.7x - 16.7x | 14.4x |
| Fair Price | (22.50) - (35.33) | (32.36) |
| Upside | -22497456.2% - -35334930.6% | -32358585.5% |
| Date | P/E |
| 2026-03-16 | -0.00 |
| 2026-03-11 | -0.00 |
| 2026-03-10 | -0.00 |
| 2026-03-06 | -0.00 |
| 2026-03-05 | -0.00 |
| 2026-03-03 | -0.00 |
| 2026-02-26 | -0.00 |
| 2026-02-19 | -0.00 |
| 2026-02-17 | -0.00 |
| 2026-02-13 | -0.00 |
| 2026-02-12 | -0.00 |
| 2026-02-09 | -0.00 |
| 2026-02-06 | -0.00 |
| 2026-02-04 | -0.00 |
| 2026-02-02 | -0.00 |
| 2026-01-30 | -0.00 |
| 2026-01-28 | -0.00 |
| 2026-01-27 | -0.00 |
| 2026-01-26 | -0.00 |
| 2026-01-23 | -0.00 |
| 2026-01-22 | -0.00 |
| 2026-01-16 | -0.00 |
| 2026-01-12 | -0.00 |
| 2026-01-09 | -0.00 |
| 2026-01-06 | -0.00 |
| 2026-01-02 | -0.00 |
| 2025-12-30 | -0.00 |
| 2025-12-29 | -0.00 |
| 2025-12-26 | -0.00 |
| 2025-12-24 | -0.00 |
| 2025-12-23 | -0.00 |
| 2025-12-22 | -0.00 |
| 2025-12-19 | -0.00 |